Future studies on a large cohort of serum samples from breast cancer patients at different stages of disease will be needed to determine whether serum Nodal expression can be used as a biomarker for staging in breast cancer or whether serum Nodal levels are affected by specific therapies. Here, NODAL is linked to breast carcinoma.